IBM: down, an analyst downgrades his rating on the title

( – IBM sells more than 4% in New York, penalized by an analysis of UBS which downgrades its rating on the title, going from ‘neutral’ to ‘sell’, with a price target reduced from 136 to 124 dollars.

The analyst is indeed revising downwards his medium-term EPS forecasts, especially after the Kyndryl spin-off.

The broker thus lowers its BPA forecasts for the 4th quarter by 18%. According to UBS, EPS 2022 and 2023 are also expected to be 12% and 10% respectively.

Copyright © 2022 All rights reserved.

Did you like this article ? Share it with your friends with the buttons below.


Source link -85

Leave a Reply